About this paper
Only a few months ago, the conversation about sharing clinical trial data was largely an argument of concerns and speculations against the idea. Spurred in part by growing momentum from government entities, the mood among life sciences companies has shifted to one of positive intention. It's just a matter of determining how to go about it. This article summarizes discussion on the topic with industry leaders at the second installment of the Clinical Trial Data Transparency Forum, sponsored by SAS, in February 2014.
SAS helps 80,000 organisations around the world take their data… And do amazing things… We help organisations turn large amounts of data into knowledge they can use, and we do it better than anyone. It’s no wonder an overwhelming majority of customers continue to use SAS year after year. Find out more, Why SAS?